Dr Mike Jones – Managing Director – Impact Minerals (ASX:IPT) is an exploration company listed on the ASX in November 2006. The Company manages extensive tenement holdings (>4,000 km2) within Australia featuring significant potential for high-grade mineral deposits of gold, silver, lead, zinc, copper, nickel and PGM’s.
Copyright 2023 – Finance News Network
Source: Finance News Network
05 June 2025 - Study results, regulatory steps and commercial roadmap
Read More30 Jul 2024 - Dr Mark Cooksey - CEO & Managing Director - ABx Group (ASX:ABX) is a uniquely positioned, Australian company delivering materials for a cleaner future. The two current areas of focus are the creation of an ionic adsorption clay rare earth project in northern Tasmania and the establishment of a plant to produce hydrogen fluoride and aluminium fluoride from recycled industrial waste, to replace imports (ALCORE).
Read More07 Sep 2023 - Empire Energy Group (ASX:EEG) CEO Alex Underwood discusses large scale future well drilling projects, and anticipates commercial production by 2025.
Read More21 Mar 2023 - Centuria Capital Group Limited (ASX:CNI) Joint CEO John McBain discusses the rising interest rate environment, the company's expansion into the healthcare and agricultural sectors, the acquisition of Primewest, and possible future M&A opportunities.
Read More11 May 2023 - Sayona Mining Limited (ASX:SYA) Finance Manager Dougal Elder provides an update on the company, discussing commercial production, the offtake agreement with Piedmont, the PFS for the lithium carbonate refinery, the upgrade of the Moblan resource, and the timeline for lithium hydroxide production.
Read More05 Apr 2023 - North Stawell Minerals Limited (ASX:NSM) CEO Russell Krause provides an update, discussing the company's progress to date, the most prospective targets, and milestones ahead.
Read More27 May 2024 - Jonathan Belz, founder of BFA Global connects Australian and Asian family offices with top global investment opportunities in venture capital, private equity, and technology. He shares insights into the future of alternative assets and investment strategies.
Read More06 Sep 2021 - Paragon Care Limited (ASX:PGC) CEO Phil Nicholl provides an update on FY21 results, which reported growth in all key financial metrics and the recommencement of dividends.
Read More22 Aug 2022 - archTIS Limited (ASX:AR9) CEO and Managing Director Daniel Lai discusses AR9's client base and growth plans, international markets, and collaborations with Microsoft and KPMG.
Read More29 Mar 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.
Read More
